The pathogenesis of cellulite: A new concept

Journal of Cosmetic Dermatology

Volumn 6, Issue 2, 2007, Pages 140-142

  Pugliese, Peter T ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; ANDROSTENEDIONE; BETA ADRENERGIC RECEPTOR; COLLAGENASE; ESTRADIOL; ESTROGEN; GENISTEIN; MATRIX METALLOPROTEINASE; PHYTOESTROGEN; PROGESTERONE; TESTOSTERONE;

ADIPOSE TISSUE; CELL PROLIFERATION; CONNECTIVE TISSUE DISEASE; DISEASE COURSE; DISEASE MARKER; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HORMONE ACTION; HORMONE DETERMINATION; HUMAN; LETTER; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SKIN FIBROBLAST;

ADIPOSE TISSUE; CONNECTIVE TISSUE DISEASES; ESTROGENS; FEMALE; FIBROBLASTS; HUMANS; MATRIX METALLOPROTEINASES; OBESITY;

EID: 34249826976     PISSN: 14732130     EISSN: 14732165     Source Type: Journal    
DOI: 10.1111/j.1473-2165.2007.00312.x     Document Type: Letter

References (43)

1. Salter SA, Batra RS, Rohrer TE, Kohli N, Kimball AB. Striae and pelvic relaxation: Two disorders of connective tissue with a strong association. J Invest Dermatol 2006; 126: 1745-8.
2. Chang AL, Agredano YZ, Kimball AB. Risk factors associated with striae gravidarum. J Am Acad Dermatol 2004; 51: 881-5.
3. Seneviratne A, Attia E, Williams RJ, Rodeo SA, Hannafin JA. The effect of estrogen on ovine anterior cruciate ligament fibroblasts. Am J Sports Med 2004; 32: 1613-8.
4. Taguchi A. Relationship between estrogen-receptor genotype and tooth loss in postmenopausal women. Clin Calcium 2003; 13: 608-10.
5. Scheutz F, Baelum V, Matee MI, Mwangosi I. Motherhood and dental disease. Community Dent Health 2002; 19: 67-72.
6. Warren MP, Fried JL. Temporomandibular disorders and hormones in women. Cells Tissues Organs 2001; 169: 187-92.
7. Yu WD, Liu SH, Hatch JD, Panossian V, Finerman GA. Effect of estrogen on cellular metabolism of the human anterior cruciate ligament. Clin Orthop Relat Res 1999; 366: 229-38.
8. Liu SH, Al-Shaikh RA, Panossian V, Finerman GA, Lane JM. Estrogen affects the cellular metabolism of the anterior cruciate ligament. A potential explanation for the female athletic injury. Am J Sports Med 1997; 25: 704-9.
9. Bray GA. The underlying basis for obesity: Relationship to cancer. J Nutr 2002; 132 Suppl. 11: 3451S-3455S.
10. Watson RE. Stretching the point: An association between the occurrence and striae and pelvic relaxation? J Invest Dermatol 2006; 126: 1688-9.
11. Curry TE Jr, Osteen KG. The matrix metalloproteinase system: Changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. Endocr Rev 2003; 24: 428-65.
12. Tabibzadeh S. The signals and molecular pathways involved in human menstruation, a unique process of tissue destruction and remodeling. Mol Hum Reprod 1996; 2: 77-92.
13. Wahrenberg H et al. Mechanism underlying regional differences in lipolysis in human adipose tissue. J Clin Invest 1989; 84: 458-67.
14. Williams CM. Lipid metabolism in women. Proc Nutr Soc 2004; 63: 153-60.
15. Ostman J et al. Regional differences in the control of lipolysis in human adipose tissue. Metabolism 1979; 28: 1198-205.
16. Arner P. Differences in lipolysis between human subcutaneous and omental adipose tissues. Ann Med 1995; 27: 435-8.
17. Liebel RL et al. Physiologic basis for the control of body fat distribution in humans. Ann Rev Nutr 1989; 9: 417-43.
18. Lockwood TE. Superficial fascial system of the trunk and extremities: A new concept. Plast Reconstr Surg 1991; 6: 1009-18.
19. Haczynski J et al. Human cultured fibroblast express estrogen receptors alpha and beta. Int J Mol Med 2002; 10: 149-53.
20. Sorrell MJ, Caplan AI. Fibroblast heterogeneity: More than skin deep. J Cell Sci 2004; 117: 667-75.
21. Hudelist G et al. Estrogen receptor beta and matrix metalloproteinase 1 are coexpressed in uterine endometrium and endometriotic lesions of patients with endometriosis. Fertil Steril October 2005; 84 (Suppl. 2): 1249-56.
22. Chen B et al. Differences in estrogen modulation of tissue inhibitor of matrix metalloproteinase-1 and matrix metalloproteinase-1 expression in cultured fibroblasts from continent and incontinent women. Am J Obstet Gynecol 2003; 189: 59-65.
23. Kokorine I et al. Expression of interstitial collagenase (matrix metalloproteinase-1) is related to the activity of human endometriotic lesions. Fertil Steril 1997; 68: 246-51.
24. Wojtys EM et al. The effect of the menstrual cycle on anterior cruciate ligament injuries in women as determined by hormone levels. A J Sports Med 2002; 30: 182-8.
25. Slauterbeck JR et al. The menstrual cycle, sex hormones, and anterior cruciate ligament injury. J Athl Train 2002; 37: 275-8.
26. Li J et al. Effects of 17 beta-estradiol on the expression of interstitial collagenases-8 and -13 (MMP-8 and MMP-13) and tissue inhibitor of metalloproteinase-1 (TIMP-1) in ovariectomized rat osteoblastic cells. J Mol Histol 2004; 35: 723-31.
27. Guan G et al. Estrogenic effect on swelling and monocytic receptor expression in an arthritic temporomandibular joint model. J Steroid Biochem Mol Biol 2005; 97: 241-50.
28. Cutulo M et al. Estrogens and autoimmune diseases. Ann NY Acad Sci 2006; 1089: 538-47.
29. Schmidt M et al. Inflammation and sex hormone metabolism. Ann NY Sci 2006; 1069: 236-46.
30. Capellino S et al. Effects of estrogen peripheral metabolism in rheumatoid arthritis. Reumatismo 2005; 57: 78-82.
31. Albelda AM, Buck CA. Integrins and other cell adhesion molecules. FASEB J 1990; 4: 2868-80.
32. Ingber DE. Cellular tensegrity: Defining new rules of biological design that govern cytoskeleton. J Cell Sci 1993; 104: 613-27.
33. Ingber DE et al. Cellular tensegrity: Exploring how mechanical changes in the cytoskeleton regulate cell growth, migration, and tissue pattern during morphogenesis. Int Rev Cytol 1994; 150: 173-224.
34. Banes AJ et al. Mechanoreception at the cellular level: The detection, interpretation, and diversity of responses to mechanical signals. Biochem Cell Biol 1995; 73: 349-65.
35. Vincent A, Fitzpatrick LA. Soy isoflavones: Are they useful in menopause? Mayo Clin Proc 2000; 75: 1174-84.
36. Webb P et al. Tamoxifen activation of the estrogen receptor/AP-1 pathway: Potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol Endocrinol 1995; 9: 443-56.
37. Harnish DC. Estrogen receptor ligands in the control of pathogenic inflammation. Curr Opin Invest Drugs 2006; 7: 997-1001.
38. Flake NM et al. Testosterone and estrogen have opposing actions on inflammation-induced plasma extravasation in the rat temporomandibular joint. Am J Physiol Regul Integr Comp Physiol 2006; 291: R343-438.
39. Herouy Y et al. Lipodermatosclerosis is characterized by elevated expression and activation of matrix metalloproteinases: Implications for venous ulcer formation. J Invest Dermatol 1998; 111: 822-7.
40. Fisher GJ et al. Molecular basis of sun induced premature skin ageing and retinoid antagonism. Nature 1996; 379: 335-9.
41. Gianelli G et al. Altered expression of basement membrane proteins and their integrin receptors in lichen planus: Possible pathogenetic role of gelatinase A and B. Lab Invest 1994; 74: 1091-104.
42. Hickey M. Mechanisms of irregular bleeding with hormone therapy: The role of matrix metalloproteinases and their tissue inhibitors. J Clin Endocrinol Metab 2006; 91: 3189-98.
43. Osteen KG. Stromal-epithelial interaction mediates steroidal regulation of metalloproteases expression in human endometrium. Proc Natl Acad Sci 1994; 91: 10129-33.